使用来自大型语言模型的合成数据检测难以治疗的抑郁症的临床特征
Isabelle Lorge1, Dan W Joyce2, Niall Taylor1
1Department of Psychiatry, University of Oxford, UK.
Computers in biology and medicine
|June 11, 2025
概括
这项研究开发了一个基于BERT的模型,使用合成数据从电子健康记录中识别难以治疗的抑郁症 (DTD) 的预后因素. 该模型成功地从临床文本中提取了关键的DTD预测因子,显示了自动化医疗保健应用的前景.
科学领域:
- 计算精神病学是一种计算精神病学.
- 在医疗保健中的自然语言处理.
- 机器学习用于临床决策支持
背景情况:
- 难以治疗的抑郁症 (DTD) 具有重大临床负担,需要改进识别方法.
- 常规收集的电子健康记录 (EHR) 叙述数据包含了对DTD有价值的预后因素.
- 目前用于提取这些因素的方法有限,需要手动注释和专家审查.
研究的目的:
- 开发和验证一个用于查询自由文本EHR数据的工具,以确定DTD的预后因素.
- 利用大型语言模型 (LLM) 和跨度提取技术进行自动化因子检测.
- 评估训练一个模型的可行性,用于临床数据提取的合成数据.
主要方法:
- 使用GPT3.5来生成合成的EHR数据.
- 训练了一个基于BERT的跨度提取模型,包含一个非最大抑制 (NMS) 算法.
- 训练模型识别和标记DTD的积极和消极预后因素.
主要成果:
- 在临床EHR数据上获得0.70F1分数,用于提取20个DTD预测因子.
- 在关键的DTD因素 (包括虐待史,家族史,疾病严重程度和自杀倾向) 上表现出高性能 (0.85F1,0.95精度).
- 成功地在合成数据上专门训练了一个模型,从临床数据中提取预后因素.
结论:
- 在合成数据上训练机器学习模型是可行的,以便从EHR中提取临床预后因素.
- 开发的跨度提取模型显示了在医疗保健中自动化DTD检测和分析的重大前景.
- 这种方法可以减少对敏感医疗数据的昂贵人类专家注释的依赖.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
201
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
201
Depressive Disorders: Etiology
56
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
56
Depression: Overview
225
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
225
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Depressive Disorders: MDD and Dysthymia
67
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
67


